LB0001 EFFICACY AND SAFETY OF UPADACITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PsA-1): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

Iain B. McInnes, J. Anderson, Marina Magrey, Joseph F. Merola, Yiqiong Liu, Mitsumasa Kishimoto, Sławomir Jeka, C.F. Pacheco Tena, X. Wang, L. Chen, Patrick Zueger, Aileen L. Pangan, Frank Behrens